PLYMOUTH, Minn., Aug. 4 ev3 Inc. (Nasdaq: EVVV),a global endovascular device company, today announced the appointment ofDouglas W. Kohrs to its Board of Directors effective immediately. Mr. Kohrswill also serve as a member of the Compensation Committee. Mr. Kohrspreviously served as a director of ev3 from June 2005 until October 2007 atwhich time Mr. Kohrs voluntarily resigned in order to facilitate thecompletion of ev3's acquisition of FoxHollow Technologies, Inc.
Mr. Kohrs is the President and Chief Executive Officer of Tornier B.V., aprivately held global orthopedic company. Prior to joining Tornier B.V., Mr.Kohrs served as Chief Executive Officer of American Medical Systems Holdings,Inc. from April 1999 until January 2005. He served on the board of directorsof American Medical Systems Holdings from 1999 to May 2006, and served aschairman of the board from March 2004 to May 2006. Mr. Kohrs is a member ofthe board of directors Tornier B.V. and The Institute for Health TechnologyStudies (InHealth), a not-for-profit medical device research organization.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to developinginnovative, breakthrough and clinically proven technologies and solutions forthe treatment of lower extremity vascular and neurovascular diseases. ev3'sproducts are used by endovascular specialists to treat a wide range ofperipheral vascular and neurovascular diseases and disorders. The companyoffers a comprehensive portfolio of treatment options, including the primaryinterventional technologies used today -- peripheral angioplasty balloons,stents, plaque excision systems, embolic protection devices, liquid embolics,embolization coils, thrombectomy catheters and occlusion balloons. Moreinformation about the company and its products can be found athttp://www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S.and other countries.
SOURCE ev3 Inc.